|
1. |
Alopecia areata: More on Pathogenesis and Therapy |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 61-63
Antonella Tosti,
Preview
|
PDF (1344KB)
|
|
ISSN:1018-8665
DOI:10.1159/000248392
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
2. |
Two-Color Flow Cytometry Analysis in Alopecia areata |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 64-66
G. Lutz,
H. Niedecken,
R. Bauer,
H.W. Kreysel,
Preview
|
PDF (1268KB)
|
|
摘要:
Since previous studies have shown that circulating T cytotoxic/suppressor cells and natural killer cells are reduced in alopecia areata (AA), we attempted to find further imbalances in mononuclear cells by double labeling with these and additional monoclonal antibodies. In all, the blood of 35 patients and 44 controls was examined using the combinations anti-Leu 3a/8, Leu 2a/8, Leu 2a/15, Leu 7/15 and Leu 7/11a. We found a highly significant reduction of the subpopulation Leu 2a+8+ (p < 0.008). The results show that patients with AA have additional abnormalities of the circulating mononuclear cells, whereby the reduced Leu 2a+8+ subpopulation represents a new additional marker.
ISSN:1018-8665
DOI:10.1159/000248393
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
3. |
Epidermal Proliferation and Accumulation of Polymorphonuclear Leukocytes in the Psoriatic Lesion |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 67-72
T. Beurskens,
A. Chang,
P.E.J. van Erp,
P.C.M. van de Kerkhof,
Preview
|
PDF (2273KB)
|
|
摘要:
Biopsies were removed from the margin of plaques in 11 untreated psoriatic patients, and 8-μm sections prepared using the cryostat. Alternate sections were stained with H and E to assess the accumulation of polymorphonuclear leukocytes.The remaining sections were stained with the monoclonal antibody Ki67 in order to determine the number of cycling epidermal cells. In areas where polymorphonuclear leukocytes occurred in the stratum Malpighi the number of cycling epidermal cells was relatively low. In contrast, a positive correlation was shown between the density of microabscesses of Munro and the number of cycling epidermal cells. The clinically uninvolved skin of psoriatic patients shows a moderate enhancement of epidermal growth in the absence of any infiltrate. In the lesional skin the recruitment of cycling epidermal cells does not coincide with the invasion of polymorphonuclear leukocytes into the epidermis, but rather follows the penetration of these cells
ISSN:1018-8665
DOI:10.1159/000248394
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
4. |
Significance of Squamous Cell Carcinoma-Related Antigen in Psoriasis and Generalized Eczema |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 73-74
Toshihiko Numahara,
Kuniyuki Nakashima,
Shinzi Yamamoto,
Masayoshi Nishimoto,
Preview
|
PDF (768KB)
|
|
摘要:
The serum levels of squamous cell carcinoma-related antigen (SCC-RAG) were assayed in 15 cases of benign dermatoses. The SCC-RAG titers (2.0 ng/ml as the cutoff value) were elevated in all cases of widespreading psoriasis (7 cases, 2.4–96.1 ng/ml) and all cases of generalized eczema (3 cases, 11.2–33.6 ng/ml). The serum SCC-RAG levels correlated with clinical course of these dermatoses. Therefore, the increase in this cancer-related antigen is not specific for SCC but may also occur in a wide range of dermato
ISSN:1018-8665
DOI:10.1159/000248395
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
5. |
Increased Mast Cell Numbers in the Sclerotic Skin of Porphyria cutanea tarda |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 75-78
Wakio Torinuki,
Kazuhiro Kudoh,
Hachiro Tagami,
Preview
|
PDF (1219KB)
|
|
摘要:
We quantitated numbers of mast cells in the sclerotic skin noted on the dorsa of the hands of 10 patients with porphyria cutanea tarda (PCT) and compared them with those of diffuse scleroderma and healthy controls. Mast cell counts in sclerodermoid skin of PCT patients were significantly greater than those in involved skin of 9 patients with diffuse scleroderma in its late stage and also greater than those in normal skin of 8 controls. When mast cell density was analyzed according to the depth of the dermis, an 84% increase was noted in the uppermost layer (0–0.2 mm in depth) and a 150% increase in the second uppermost layer (0.2–0.4 mm in depth) in the patients with PCT when compared with those in the corresponding sites of the controls. These results suggest a possible role of mast cells in the pathogenesis of sclerodermoid skin of
ISSN:1018-8665
DOI:10.1159/000248396
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
6. |
Overview of Recent Clinical Pharmacokinetic Studies with Acitretin (Ro 10-1670, Etretin) |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 79-87
C.J. Brindley,
Preview
|
PDF (1844KB)
|
|
摘要:
Following oral administration of acitretin with food, peak plasma concentrations of unchanged drug (Ro 10-1670) are reached within 4 h. The mean absolute bioavailabihty of acitretin is 59% with high interpatient variability consistent with that of etretinate. Taking acitretin with food results in an increased and more consistent bioavailabihty. The drug appears to be extensively distributed throughout the body without unexpected accumulation and the elimination half-life is approximately 50 h. Acitretin has a profound pharmacokinetic advantage over etretinate because it is eliminated more rapidly from the body; etretinate is sequestered into fatty tissue due to its greater lipophilicity creating a deep compartment from which it is only slowly released. Acitretin is eliminated entirely by the metabolism and the resultant metabolites are excreted via the kidney and bile.
ISSN:1018-8665
DOI:10.1159/000248397
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
7. |
Benefit of Progressively Increasing Doses during the Initial Treatment with Acitretin in Psoriasis |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 88-92
P. Berbis,
J.-M. Geiger,
C. Vaisse,
C. Rognin,
Y. Privat,
Preview
|
PDF (1732KB)
|
|
摘要:
The purpose of this double-blind study was to compare the therapeutic effects of a low initial dosage of acitretin, increased at 2-week intervals (group 1:10, 30, 50 mg/day) with a high initial dosage decreased at similar intervals (group 3: 50, 30, 10 mg/day) and with a constant dosage (group 2: 30 mg/day) in 66 patients (47 men and 19 women) with severe psoriasis. At the end of the double-blind phase the mean percent improvement calculated by the Psoriasis Area and Severity Index score, was as follows: 62.7% in group 1, 55.9% in group 2 and 67.1% in group 3.The double-blind phase of 6 weeks was followed by an open phase of 6 weeks, during which the patients were treated either with 10, 30 or 50 mg/day, according to the therapeutic response. At the end of treatment (12 weeks), a mean improvement of more than 80% was obtained in all three groups. Hypervitaminosis A signs and symptoms were observed in all patients. The frequency and severity of these adverse reactions were shown to be dose-dependent. This study shows that a low dose progressively increased is advisable because of similar activity and better acceptability.
ISSN:1018-8665
DOI:10.1159/000248398
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
8. |
Investigations on the Development and Regression of Corticosteroid-Induced Thinning of the Skin in Various Parts of the Human Body during and after Topical Application of Amcinonide |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 93-97
Dietrich Lubach,
Heide Grüter,
Michael Behl,
Cornelia Nagel,
Preview
|
PDF (2099KB)
|
|
摘要:
In 15 subjects 6 different parts of the body were treated with the potent topical corticosteroid (CS) amcinonide once a day for 21 days. The skin thickness of the treated areas was measured sonographically at intervals of 2 days. After completion of the CS application the regression of the CS-induced reduction in skin thickness was measured for a further 14 days. Aclear thinning of the skin could be measured after only 4 days and continued up to the 21st day of treatment. This thinning regressed completely in all areas after 10–12 days. The thinning and regression curves were very similar for all body areas. Differences in intensity of thinning were evident. No tachyphylaxis was detecte
ISSN:1018-8665
DOI:10.1159/000248399
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
9. |
Double-Blind Placebo-Controlled Study with Topical 2% Ketanserin Ointment in the Treatment of Venous Ulcers |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 98-102
P. Roelens,
Preview
|
PDF (2091KB)
|
|
摘要:
Previous animal and human data have shown that ketanserin, the first specific serotonin2 antagonist, may have beneficial effects on peripheral vascular diseases and on the healing of ulcers. In this double-blind study a 2% ketanserin ointment in a polyethylene glycol base was used to treat 23 patients with venous ulcers (13 ketanserin, 10 placebo). Classical wound care measures were maintained in both groups; therefore, conventional ulcer therapy (with placebo in a polyethylene glycol base) was in reality compared with conventional ulcer treatment plus ketanserin. The most important parameter for evaluation in this study was the development of granulation tissue (first sign of successful wound healing). The evolution of granulation was significantly better with ketanserin than with placebo (p < 0.05, Mann-Whitney U test). According to the investigator’s evaluation, ketanserin showed a response in 10 out of 11 patients as opposed to 5 out of 10 placebo patients at the end of the study. This first double-blind placebo-controlled study suggests that topically applied ketanserin promotes the healing of venous ulcer
ISSN:1018-8665
DOI:10.1159/000248400
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
10. |
In vivo Effects of Terbinafine and Ketoconazole on Testosterone Plasma Levels in Healthy Males |
|
Dermatology,
Volume 178,
Issue 2,
1989,
Page 103-106
I. Effendy,
W. Krause,
Preview
|
PDF (1295KB)
|
|
摘要:
Ten healthy male volunteers received daily 200 mg of ketoconazole or 500 mg of terbinafine (SF 86-327) for a period of 8 days according to a crossover double-blind design. Between the periods of treatment there was an interval of 3 weeks. Before and during the treatments, on 3 days in all, blood levels of testosterone were determined in the morning at 08.00 and 12.00 h. On the following day in each case, after taking a basal blood sample, 5,000 IU of hCG were injected intravenously and 2 h later a further blood sample for plasma testosterone determination was taken (short-term hCG stimulation test). Prior to treatment, the mean plasma testosterone levels at 12.00 h were slightly below the level at 08.00 h (6.5 ± 3.5 against 7.2 ± 3.1 ng/ml).The difference increased and was statistically significant with ketoconazole treatment (4.2 ± 3.2 against 7.7 ± 3.0 ng/ml), but did not alter during administration of terbinafine (7.8 ± 4.4 against 6.8 ± 3.0 ng/ml). The administration of testosterone levels by hCG stimulated 25.6% prior to treatment. The stimulation was suppressed to zero by ketoconazole but clearly intensified (41.7%) by terbinafine treatment. The results demonstrate once more the well-known effect of ketoconazole on testosterone production and confirm that terbinafine obviously does not have this e
ISSN:1018-8665
DOI:10.1159/000248401
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
|